Register information Patent

DE file number : 60 2011 071 528.3 (Status: pending/in force, Query started: April 24, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INIDCriterionFieldContent
Type of IP rightSARTPatent
StatusSTPending/in force
21DE file number DAKZ60 2011 071 528.3
96EP file numberEAKZ19 19 2679.9
97EP publication numberEPN3626258
54Designation/titleTIVERFAHREN UND ZUSAMMENSETZUNGEN ZUR ZNS-ABGABE VON IDURONAT-2-SULFATASE
51IPC main classICM
(ICMV)		 A61K 38/47 (2006.01)
51IPC secondary class(es)ICS
(ICSV)		 A61P 25/00 (2006.01), A61P 25/28 (2006.01), A61K 9/19 (2006.01), A61K 38/46 (2006.01)
22DE application dateDATJun 25, 2011
96EP application dateEATJun 25, 2011
43Date of first publicationOTMar 25, 2020
Date of publication of grantPETAug 4, 2021
71/73Applicant/ownerINHTakeda Pharmaceutical Company Limited, Osaka-shi, Osaka, JP
72InventorINZHU, Gaozhong, Weston, MA Massachusetts 02493, US; LOWE, Kris, Boston, MA Massachusetts 02120, US; SHAHROKH, Zahra, Weston, MA Massachusetts 02493, US; CHRISTIAN, James, Grafton, MA Massachusetts 01519, US; FAHRNER, Rick, Boxford, MA Massachusetts 01921, US; PAN, Jing, Boxborough, MA Massachusetts 01719, US; WRIGHT, Teresa, Leah, Lexington, MA Massachusetts 02142, US; CALIAS, Pericles, Melrose, MA Massachusetts 02176, US
74RepresentativeVTRMüller-Boré & Partner Patentanwälte PartG mbB, 80639 München, DE
Address for service Müller-Boré & Partner Patentanwälte PartG mbB, 80639 München, DE
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
38786210 P
Sep 29, 2010
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
201161435710 P
Jan 24, 2011
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
201161442115 P
Feb 11, 2011
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
36078610 P
Jul 1, 2010
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
35885710 P
Jun 25, 2010
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
201161476210 P
Apr 15, 2011
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
201161495268 P
Jun 9, 2011
Due dateFT
FG		Jun 30, 2025
Annual fee for the 15th year Patent fees
Patent division in charge 44
97EP language of publicationELANGEN - Englisch
84Designated EP contracting statesEDSAL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Published EP/WO documentsEPWOPNOriginal document: EP000003626258A1
Searchable text: EP000003626258A1
Original document: EP000003626258B1
Searchable text: EP000003626258B1
43Date of first publicationEVTMar 25, 2020
Date of the first transfer into DPMAregisterEREGTMar 24, 2020
Date of the (most recent) update in DPMAregisterREGTAug 1, 2024
(Show all update days)(Hide all update days)
  • Aug 1, 2024
    • St.36: changed (technical change)
  • May 28, 2024; Nov 9, 2023; Oct 3, 2023; Jun 3, 2023; May 26, 2022; May 24, 2022; May 19, 2022; Sep 10, 2021; Aug 12, 2021; Jul 15, 2021
    • Historical data not available for this/these date(s)
  • Mar 24, 2020
    • Date of the first transfer into DPMAregister
Procedural data
No.Kind of procedureLegal statusDate of legal/procedural statusPublication dateAlle Details anzeigen
1 Procedure relating to EP application EPO 1st publication Mar 25, 2020  Details anzeigen
2 Publications Publication of a mention regarding EP 1st publication by DPMA May 7, 2020 May 7, 2020 Details anzeigen
3 Procedure relating to EP application EPO publication of mention regarding patent grant (beginning of opposition period) Aug 4, 2021  Details anzeigen
4 Publications Publication by DPMA of mention regarding EP patent grant Aug 19, 2021 Aug 19, 2021 Details anzeigen
5 Opposition procedure Opposition to patent filed May 3, 2022 Jun 23, 2022 Details anzeigen
6 New applicant/owner details New applicant/owner details Oct 2, 2023 Nov 9, 2023 Details anzeigen
View procedures Procedure relating to EP application (No.: 1)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO 1st publication
Date of legal/procedural statusVSTTMar 25, 2020
View procedures Publications (No.: 2)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication of a mention regarding EP 1st publication by DPMA
Date of legal/procedural statusVSTTMay 7, 2020
Issue numberHN19
YearPJ2020
Publication dateVTMay 7, 2020
Type of publicationPARTBibliographic data
View procedures Procedure relating to EP application (No.: 3)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO publication of mention regarding patent grant (beginning of opposition period)
Date of legal/procedural statusVSTTAug 4, 2021
Date of update of the procedureREGTJul 15, 2021
View procedures Publications (No.: 4)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication by DPMA of mention regarding EP patent grant
Date of legal/procedural statusVSTTAug 19, 2021
Issue numberHN33
YearPJ2021
Publication dateVTAug 19, 2021
Type of publicationPARTBibliographic data
PartHTPart 5
Date of update of the procedureREGTAug 12, 2021
View procedures Opposition procedure (No.: 5)
INIDCriterionFieldContent Close details
Type of procedureVARTOpposition procedure
Legal/procedural statusVSTOpposition to patent filed
Date of legal/procedural statusVSTTMay 3, 2022
Issue numberHN25
YearPJ2022
Publication dateVTJun 23, 2022
Type of publicationPARTBibliographic data
PartHTPart 3
Date of update of the procedureREGTMay 26, 2022
View procedures New applicant/owner details (No.: 6)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTOct 2, 2023
Issue numberHN45
YearPJ2023
Publication dateVTNov 9, 2023
Type of publicationPARTBibliographic data
PartHTPart 3
71/73Applicant/ownerINHTakeda Pharmaceutical Company Limited, Osaka-shi, Osaka, JP
71/73Previous applicant/ownerINHFShire Human Genetic Therapies, Inc., Lexington, MA, US
Date of update of the procedureREGTNov 9, 2023